CSIMarket
 


Bio techne Corp  (TECH)
Other Ticker:  
 

Cumulative Bio Techne's Quick Ratio for Trailing Twelve Months Period

TECH's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

TECH Quick Ratio for Trailing Twelve Months Period

(Dec 31 2023)
II. Quarter
(Sep 30 2023)
I. Quarter
(Jun 30 2023)
IV. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
II. Quarter
Y / Y Current Liabilities Growth 5.32 % -7.18 % -26.99 % -15.39 % -17.06 %
Y / Y Cash & cash equivalent Growth -31.06 % -26.79 % -17.29 % -32 % -29.47 %
Quick Ratio for Trailing Twelve Months Period 1.21 1.34 1.42 1.38 1.44
Total Ranking # 676 # 1187 # 1256 # 1407 # 1650
Seq. Current Liabilities Growth 5.85 % -0.59 % -8.96 % 9.94 % -6.71 %
Seq. Cash & cash equivalent Growth -8.75 % -27.24 % 29.97 % -20.11 % -3.11 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Due to rise in Current Liabilities in the II. Quarter to $135 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 1.21 below Bio Techne Corp average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 51 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Bio Techne. While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about TECH
Quick Ratio TECH in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 52
Sector # 299
S&P 500 # 770


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
10.25 2.95 1.01
(June 30. 2014)   (Jun 30 2017)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Biotechnology & Pharmaceuticals Industry Quick Ratio for Trailing Twelve Months Period
Erytech Pharma S a   3.32 
Exelixis Inc   3.32 
Immunocore Holdings Plc  3.22 
Arcellx Inc   3.10 
Vericel Corporation  3.07 
Precision Biosciences Inc  2.99 
Lineage Cell Therapeutics Inc   2.80 
Biomx Inc   2.75 
Aptose Biosciences Inc   2.75 
Regenxbio Inc   2.70 
Sqz Biotechnologies Company  2.62 
Gamida Cell Ltd   2.57 
Orchard Therapeutics Plc  2.55 
Relay Therapeutics Inc   2.51 
Fate Therapeutics Inc   2.51 
Adaptimmune Therapeutics Plc  2.46 
Atara Biotherapeutics Inc   2.44 
Tcr2 Therapeutics Inc   2.33 
Windtree Therapeutics Inc  2.31 
Halozyme Therapeutics Inc   2.29 
Tracon Pharmaceuticals Inc   2.24 
Bluebird Bio Inc   2.24 
Moderna Inc   2.21 
Sangamo Therapeutics Inc   2.20 
Cellectis S a   2.17 
Biondvax Pharmaceuticals Ltd   2.11 
Innate Pharma Sa  2.04 
Qiagen N v   1.83 
Seagen Inc   1.79 
Evaxion Biotech A  1.78 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com